2018
DOI: 10.1186/s12904-018-0292-6
|View full text |Cite
|
Sign up to set email alerts
|

Development of the Japanese version of an information aid to provide accurate information on prognosis to patients with advanced non–small-cell lung cancer receiving chemotherapy: a pilot study

Abstract: BackgroundWithout explicit prognostic information, patients may overestimate their life expectancy and make poor choices at the end of life. We sought to design the Japanese version of an information aid (IA) to provide accurate information on prognosis to patients with advanced non–small-cell lung cancer (NSCLC) and to assess the effects of the IA on hope, psychosocial status, and perception of curability.MethodsWe developed the Japanese version of an IA, which provided information on survival and cure rates … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 38 publications
(47 reference statements)
0
1
0
Order By: Relevance
“…Of the included studies, 6 were pre-post single group studies, 32–37 5 were quasi-experimental, 3842 and 24 were RCTs. 15,19,20,4363 The majority of the studies were conducted in the US ( n = 10), followed by Canada ( n = 5), Iran ( n = 5), Australia ( n = 4), UK ( n = 4), and Japan ( n = 3).…”
Section: Resultsmentioning
confidence: 99%
“…Of the included studies, 6 were pre-post single group studies, 32–37 5 were quasi-experimental, 3842 and 24 were RCTs. 15,19,20,4363 The majority of the studies were conducted in the US ( n = 10), followed by Canada ( n = 5), Iran ( n = 5), Australia ( n = 4), UK ( n = 4), and Japan ( n = 3).…”
Section: Resultsmentioning
confidence: 99%